ELTX · Elicio Therapeutics, Inc. · Fails to Deliver
$2.05
-0.06 (-2.84%)
At close · Sep 11
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We are currently facing substantial doubt about our ability to continue as a going concern, given our cash position and cash runway.”View the 10-Q filed Aug 13, 2026
Market Cap
$53.88M
Shares
26.28M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-14 | 4,274 | $3.15 | $13,463 |
| 2026-08-12 | 1,954 | $3.03 | $5,921 |
| 2026-08-06 | 1,195 | $3.19 | $3,812 |
| 2026-08-05 | 98 | $3.16 | $310 |
| 2026-08-04 | 1,649 | $2.86 | $4,716 |
| 2026-08-03 | 24,487 | $2.80 | $68,564 |
| 2026-07-31 | 6,884 | $2.91 | $20,032 |
| 2026-07-27 | 1 | $3.00 | $3 |
| 2026-07-24 | 5,609 | $3.15 | $17,668 |
| 2026-07-23 | 5,213 | $3.12 | $16,265 |
| 2026-07-22 | 3,449 | $3.08 | $10,623 |
| 2026-07-20 | 2,234 | $3.11 | $6,948 |
| 2026-07-17 | 499 | $3.20 | $1,597 |
| 2026-07-15 | 29,578 | $3.11 | $91,988 |
| 2026-07-14 | 31,200 | $3.29 | $102,648 |
| 2026-07-09 | 727,692 | $3.49 | $2,539,645 |
| 2026-07-08 | 935,080 | $2.80 | $2,618,224 |
| 2026-07-07 | 950 | $3.30 | $3,135 |
| 2026-07-06 | 87,058 | $3.22 | $280,327 |
| 2026-07-02 | 25,068 | $5.14 | $128,850 |
| 2026-07-01 | 35,610 | $3.91 | $139,235 |
| 2026-06-30 | 49,851 | $4.00 | $199,404 |
| 2026-06-29 | 48,351 | $4.00 | $193,404 |
| 2026-06-26 | 3,555 | $3.75 | $13,331 |
| 2026-06-25 | 14,359 | $3.98 | $57,149 |
| 2026-06-24 | 61,410 | $4.11 | $252,395 |
| 2026-06-23 | 668,142 | $4.14 | $2,766,108 |
| 2026-06-22 | 1,437,702 | $3.85 | $5,535,153 |
| 2026-06-18 | 660,446 | $4.71 | $3,110,701 |
| 2026-06-17 | 422,002 | $2.76 | $1,164,726 |
| 2026-06-16 | 360,846 | $4.08 | $1,472,252 |
| 2026-06-15 | 8,642 | $14.85 | $128,334 |
Showing 1–32 of 32 settlements
Key facts
CIK
1601485
CUSIP
28657F103
13F (30d)
19 filings
19 filers
Visit website
Investor relations